Search

Your search keyword '"ARCURI, C."' showing total 382 results

Search Constraints

Start Over You searched for: Author "ARCURI, C." Remove constraint Author: "ARCURI, C."
382 results on '"ARCURI, C."'

Search Results

201. Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib.

202. PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT.

203. Effect of Vitamin D in HN9.10e Embryonic Hippocampal Cells and in Hippocampus from MPTP-Induced Parkinson's Disease Mouse Model.

204. Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes.

205. Human papilloma virus in the tonsillar microbiota of an Afghan population group.

206. HPV acting on E-cadherin, p53 and p16: literature review.

207. Human Papilloma Virus associated with oral cancer and preventive strategies: the role of vaccines.

208. Radiosurgery-assisted gingival displacement: a proof of concept technique to enhance the efficiency of intraoral digital impression.

209. Oxidative stress-induced S100B accumulation converts myoblasts into brown adipocytes via an NF-κB/YY1/miR-133 axis and NF-κB/YY1/BMP-7 axis.

210. Clinical protocol with digital cad/cam chairside workflow for the rehabilitation of severely worn dentition patients.

211. The Pathophysiological Role of Microglia in Dynamic Surveillance, Phagocytosis and Structural Remodeling of the Developing CNS.

213. Lysosomal alpha-mannosidase and alpha-mannosidosis.

214. Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson's Disease and in Embryonic Hippocampal Cells.

215. Microglia-glioma cross-talk: a two way approach to new strategies against glioma.

216. Preservation of extraction socket in immediate implant placement: a clinical study.

217. The treatment of peri-implant diseases: a new approach using hybenx ® as a decontaminant for implant surface and oral tissues.

218. Increasing volume of vestibular soft tissues in flapless implant surgery through a modified connective punch technique: a controlled clinical trial.

219. Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome.

220. HPV and oral lesions: preventive possibilities, vaccines and early diagnosis of malignant lesions.

221. Transcrestal guided sinus lift without grafting materials: a 36 months clinical prospective study.

222. Sem analysis zirconia-ceramic adhesion interface.

223. Autologous blood preparations rich in platelets, fibrin and growth factors.

224. Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto's thyroiditis.

225. Autogenous Tooth Fragment Adhesive Reattachment for a Complicated Crown Root Fracture: Two Interdisciplinary Case Reports.

226. Tunnel Traction Procedure for Deeply Impacted Canines and Resorbed Lateral Incisors.

227. Oral complications of head and neck radiotherapy: prevalence and management.

228. CEREC CAD/CAM Chairside System.

229. Palatal obturators in patients after maxillectomy.

230. [Epidemiology of third molar extractions: the experience of the S.G.C. Fatebenefratelli Hospital in Rome (Italy)].

231. NGF induces the expression of group IIA secretory phospholipase A2 in PC12 cells: the newly synthesized enzyme is addressed to growing neurites.

232. Medical waste to energy: experimental study.

233. Clinical assessment of submerged vs non-submerged implants placed in pristine bone.

234. Mechanical evaluation and fem analysis of stress in fixed partial dentures zirconium-ceramic.

235. Atomic force microscopy of bacteria from periodontal subgingival biofilm: Preliminary study results.

236. S100B protein in tissue development, repair and regeneration.

237. Podoplanin in the development and progression of oral cavity cancer: a preliminary study.

238. Prevalence, distribution, and differential diagnosis of nasopalatine duct cysts.

239. Understanding the implications of the PAX9 gene in tooth development.

240. Palatal-implant anchorage in an adult class II patient.

241. Oral cavity rare lesions: 15 years case histories.

242. S100B in myoblasts regulates the transition from activation to quiescence and from quiescence to activation and reduces apoptosis.

243. Extraction of a geminated central incisor.

244. Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer.

245. Fragile-X syndrome: genetic aspects and stomatologic evaluations.

246. The evaluation of disphagic syndrome, in patients with previously acquired brain damages.

247. S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression.

248. Cemento-ossyfying fibroma juvenile of the oral cavity.

249. The many faces of S100B protein: when an extracellular factor inactivates its own receptor and activates another one.

250. S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond.

Catalog

Books, media, physical & digital resources